NCT00249392

Brief Summary

Environmental and genetic factors may play a role in the progression of ocular diseases (cataract, retinopathy, age-related macular degeneration, glaucoma, retinal detachment, ocular tumor, etc.). The goal of this project is to establish a series of case-control studies to evaluate risk factors of ocular diseases in China.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
800

participants targeted

Target at P75+ for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2004

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

November 4, 2005

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 7, 2005

Completed
Last Updated

May 23, 2008

Status Verified

May 1, 2008

First QC Date

November 4, 2005

Last Update Submit

May 22, 2008

Conditions

Ocular Diseases

Keywords

ocular diseasesrisk factorsgenetic factors

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • This is a study only of Chinese.
  • Subjects will be allowed to participate if they self-identify as Chinese.
  • Individuals with ocular diseases (cataract, retinopathy, age-related macular degeneration, glaucoma, retinal detachment, ocular tumor, etc.) will be allowed to participate. To participate in the study as the control, subjects should be confirmed without ocular diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Pharmacology, Institute of Clinical Pharmacology, Nanjing Medical University

Nanjing, Jiangsu, 210029, China

Location

Study Officials

  • Bin Wang, Ph.D

    Department of Pharmacology, Institute of Clinical Pharmacology, Nanjing Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 4, 2005

First Posted

November 7, 2005

Study Start

October 1, 2004

Last Updated

May 23, 2008

Record last verified: 2008-05

Locations

CN(1)